MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2025

Jun 19, 2025

ASX Announcement

20 June 2025

==> picture [104 x 26] intentionally omitted <==

MACH7 SIGNS A$5M LICENCE AGREEMENT AMENDMENT

Mach7 Technologies Limited (“M7T” or “the Company”) (ASX:M7T) today announces it has signed a 5-year licence agreement amendment for a Total Contract Value (TCV) of A$5M with a longstanding key customer, a large US-based radiology marketplace.

The amended agreement is for additional eUnity Viewer and Enterprise Imaging Platform licensing and extends the term of the previous subscription licence by three years.

The revised agreement is effective from 1 June 2025 and represents a A$3M increase in TCV over the original agreement.

Mach7 CEO Mike Lampron said: “The agreement highlights our focus on building lasting relationships with our customers and the importance of our ‘land and expand’ strategy. It also demonstrates the strength of our value proposition and the significant ROI that our diverse product offering delivers to our customers.”

Released on authority of the Board by:

Mike Lampron Managing Director and Chief Executive Officer

For more information, contact:

Investor Relations Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a medical imaging technology provider that develops innovative data management and image viewing solutions for healthcare organizations. Its core offering is the Mach7 Enterprise Imaging Solution (EIS), a next-generation platform built for the future of healthcare, comprised of a Vendor Neutral Archive (VNA), eUnity Enterprise Diagnostic Viewer, and Diagnostic Workflow Applications. Designed to maximize flexibility and scalability, Mach7 gives customers the independence to deploy a full enterprise solution or individual components. Mach7 serves a global network of customers, ranging from expansive IDNs and National Health Systems to small, independent provider groups and private radiology practices. Visit Mach7t.com for more information.

1

==> picture [104 x 26] intentionally omitted <==

ASX Announcement

Forward-looking statements

This announcement may contain forward-looking statements regarding the Company’s financial position, business strategy and objectives (rather than being based on historical or current facts). Any forward-looking statements are based on the current beliefs of the Company’s management as well as assumptions made by, and information currently available to, the Company’s management. Forward-looking statements are inherently uncertain and must be read accordingly. There can be no assurance that some or all of the underlying assumptions will prove to be valid.

All data presented in this announcement reflects the current views of the Company with respect to future events. Forward-looking statements are subject to risk, uncertainties and assumptions relating to the operations, results of operations, growth strategy and liquidity of the Company. To the maximum extent permitted by law, the Company, its officers, employees and agents do not accept any obligation to release any updates or revisions to the information (including any forward-looking statements) in this announcement to reflect any change to expectations or assumptions; and disclaim all responsibility and liability for any loss arising from reliance on this announcement or its contents.

==> picture [150 x 11] intentionally omitted <==

==> picture [150 x 12] intentionally omitted <==

==> picture [150 x 12] intentionally omitted <==

==> picture [150 x 11] intentionally omitted <==

==> picture [150 x 11] intentionally omitted <==

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com

2